Physician profile
Edward Graham
NPI 1417525361
$2,268.43
in general payments reported to CMS, 2019-2025
11 companies · $723 in 2025
The $723 reported for 2025 was more than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $365 · 2022: $240 · 2023: $584 · 2024: $356 · 2025: $723.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,664.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,663.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $895.42 | 2021-2025 | |
| Neurocrine Biosciences, INC. | $631.49 | 2022-2025 | Ingrezza |
| Otsuka America Pharmaceutical, INC. | $163.49 | 2023-2025 | Rexulti, Abilify Maintena, Abilify Asimtufii |
| Teva Pharmaceuticals USA, INC. | $154.96 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $145.66 | 2025 | Cobenfy |
| Vanda Pharmaceuticals INC. | $124.97 | 2024 | Fanapt |
| Lundbeck LLC | $61.28 | 2023-2025 | Rexulti |
| Janssen Pharmaceuticals, INC | $29.37 | 2023 | Spravato |
| Almatica Pharma LLC | $23.02 | 2024 | Loreev Xr |
| Alkermes, INC. | $21.60 | 2025 | Aristada, Lybalvi |
| Axsome Therapeutics, INC. | $17.17 | 2023 | Auvelity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Graham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.